CLDX

NASDAQStock

Celldex Therapeutics, Inc.

$29.72-1.51 (-4.84%)

52-Week Range

$15.13

$31.23

Key Stats

Market Cap

2.0B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26

Volume

351.9K

Avg Volume

1.2M

Performance

+21.46%

+10.30%

+21.96%

YTD

+10.63%

+48.36%

-32.12%

+19.57%

Price Chart

ETF Exposure

CLDX is held by 77 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
DFUS	Dimensional - US Equity Market ETF	0.01%	27,226	$848K	$18.80B	0.09%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	84,563	$2.6M	$81.53B	0.03%
IWV	iShares Russell 3000 ETF	0.00%	16,630	$518K	$17.58B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.00%	37,550	$1.2M	$38.14B	0.03%
AVUS	Avantis U.S. Equity ETF	0.00%	5,394	$168K	$11.08B	0.15%
DFSU	Dimensional - US Sustainability Core 1 ETF	0.00%	1,026	$32K	$1.91B	0.15%
EAOA	iShares ESG Aware 80/20 Aggressive Allocation ETF	0.00%	38	$1K	$33.4M	0.34%
VTHR	Vanguard Russell 3000 ETF	0.00%	5,031	$124K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	2,120,497	$52.2M	$2.10T	0.03%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	4	$121	$9.0M	0.30%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	5	$150	$8.3M	0.31%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	26	$814	$30.3M	0.32%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	31	$964	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	36	$1K	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	42	$1K	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	35	$1K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	23	$722	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	18	$546	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	8	$242	$9.5M	0.12%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	6	$171	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	18	$566	$81.5M	0.10%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	1,520	$39K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	1,520	$39K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	1,520	$39K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	1,520	$39K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	1,520	$39K	$3.7M	0.70%

PreviousPage 2 of 2

About CLDX ETF Exposure

Celldex Therapeutics, Inc. (CLDX) is held by 77 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.0B, CLDX is a widely held institutional stock. The stock currently trades at $29.72. Investors can gain exposure to CLDX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CLDX, sorted by portfolio weight.